Atlas Trials

SARS-CoV-2 and Herpesvirus Inhibition for Ending Long COVID Dysfunction

Clinical trial NCT07597902 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07597902
Sponsor
Icahn School of Medicine at Mount Sinai
Status
NOT_YET_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Post-acute Sequelae of COVID-19Long COVID
Start date
2026-06-01
Primary completion
2028-06-30
Enrollment
150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.